New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting

S.L. Schlereth*, D. Hos*, M. Matthaei, P. Hamrah, L. Schmetterer, O. O'Leary, C. Ullmer, J. Horstmann, F. Bock, K. Wacker, H. Schroder, M. Notara, M. Haagdorens, R.M.M.A. Nuijts, S. Dunker, M. Dickman, S. Fauser, H.P.N. Scholl, T. Wheeler-Schilling, C. Cursiefen

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)145-167
Number of pages23
JournalOphthalmic Research
Volume64
Issue number2
DOIs
Publication statusPublished - 1 Mar 2021

Keywords

  • Cornea
  • Limbal stem cell deficiency
  • Dry eye disease
  • End points
  • European vision institute
  • Diagnostic
  • New technologies
  • Anterior segment OCT
  • Confocal laser scanning microscopy
  • Fuchs endothelial dystrophy
  • Graft versus host disease
  • OPTICAL COHERENCE TOMOGRAPHY
  • VIVO CONFOCAL MICROSCOPY
  • TEAR FILM THICKNESS
  • MEMBRANE ENDOTHELIAL KERATOPLASTY
  • DRY EYE DISEASE
  • VERSUS-HOST-DISEASE
  • ANTERIOR LAMELLAR KERATOPLASTY
  • MEIBOMIAN GLAND DYSFUNCTION
  • IN-VIVO
  • OCULAR SURFACE

Cite this